SEQUA
vs
ABT
SEQUA
ABT
Over the past 12 months, SEQUA has underperformed ABT, delivering a return of -73% compared to the ABT's 15% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
SEQUA
ABT
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Sequana Medical NV
XBRU:SEQUA
|
0.565
EUR
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
109.18
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
SEQUA, ABT
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Sequana Medical NV
Revenue
|
|||||||||||
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
SEQUA, ABT
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Sequana Medical NV
XBRU:SEQUA
|
|||||||||
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Sequana Medical NV | ||||
|
Abbott Laboratories | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
SEQUA, ABT
Performance Gap
SEQUA, ABT
Performance By Year
SEQUA, ABT
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.